Ptns with ESRD on DX, the prevalence of COVID-19 seems to be varied by geographic zones, from <1 % in certain zones in France to 36 % in urban zones o
Ptns on in-centre HDX typically presented to an out-ptn facility times/wk to be maintained DX that results in limitation of the ability of observing physical isolation necessary for infection control, that is contributing to a higher risk of infection in this cohort. One study from France conducted ptns maintained on in-centre DX had almost prevalence of of infectious episodes as compared to those maintained on home DX. The reported COVID-19 in DX ptns is higher but largely representing the general cohorts within certain zones. This is illustrated in the following studies:
MR among DX ptns with COVID-19 was about % in 2 large reports. The CDC, ASN, & ISN have issued preliminary guidelines to guide nephrologists providing life-maintained DX care. These resources are currently and continuously updated. Minimally, all DX centres are supposed to strictly follow these recommendations. Certain DX organizations may currently follow more measures protecting the health carer staff & their ptns, according to their protective tools and other facilities.
o Jager KJ, Kramer A, Chesnaye NC, et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe. Kidney Int 2020; 98:1540.
o Centers for Disease Control and Prevention. Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities. https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis.html (Accessed on April 08, 2020).